Filing Details
- Accession Number:
- 0001999371-24-012789
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-01 17:54:39
- Reporting Period:
- 2024-09-27
- Accepted Time:
- 2024-10-01 17:54:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1631574 | Wave Life Sciences Ltd. | WVE | Pharmaceutical Preparations (2834) | X0 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1131399 | Plc Gsk | 79 New Oxford Street London X0 WC1A 1DG | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2024-09-27 | 2,791,930 | $8.00 | 16,775,691 | No | 4 | P | Indirect | By Corporation |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Corporation |
Footnotes
- The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").
Billionaire Hedge Funds
